Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2025)

Historic Exchange Rate Effect for Vanda Pharmaceuticals (VNDA) over the last 9 years, with Q4 2025 value amounting to $20000.0.

  • Vanda Pharmaceuticals' Exchange Rate Effect rose 10990.1% to $20000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $23000.0, marking a year-over-year increase of 11411.04%. This contributed to the annual value of $23000.0 for FY2025, which is 11411.04% up from last year.
  • As of Q4 2025, Vanda Pharmaceuticals' Exchange Rate Effect stood at $20000.0, which was up 10990.1% from -$180000.0 recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Exchange Rate Effect peaked at $183000.0 during Q4 2022, and registered a low of -$202000.0 during Q4 2024.
  • Over the past 5 years, Vanda Pharmaceuticals' median Exchange Rate Effect value was $3000.0 (recorded in 2021), while the average stood at $4050.0.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 94166.67% in 2021, then surged by 99333.33% in 2025.
  • Quarter analysis of 5 years shows Vanda Pharmaceuticals' Exchange Rate Effect stood at -$101000.0 in 2021, then surged by 281.19% to $183000.0 in 2022, then decreased by 18.03% to $150000.0 in 2023, then tumbled by 234.67% to -$202000.0 in 2024, then soared by 109.9% to $20000.0 in 2025.
  • Its Exchange Rate Effect stands at $20000.0 for Q4 2025, versus -$180000.0 for Q3 2025 and $134000.0 for Q2 2025.